Australia markets closed

Silo Pharma, Inc. (SILO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.8500+0.0100 (+0.54%)
At close: 04:00PM EDT
1.8499 -0.00 (-0.01%)
After hours: 05:56PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-3,701
-3,701
-3,909
3,904
-3,038
Stock-based compensation
104.192
104.192
156.047
191.698
1,189
Change in working capital
299.275
299.275
-75.288
729.714
-72.138
Inventory
-
-
-
-
-15.065
Accounts payable
339.272
339.272
-53.721
-
-
Other working capital
-3,224
-3,224
-3,498
-2,278
-1,157
Other non-cash items
-
-
-85.733
-1.553
268.125
Net cash provided by operating activities
-3,224
-3,224
-3,498
-2,278
-1,157
Cash flows from investing activities
Purchases of investments
-4,147
-4,147
-
-
0
Sales/maturities of investments
-
-
66.707
7,021
0
Other investing activities
-
-
20
172
39
Net cash used for investing activities
-4,147
-4,147
86.707
7,193
39
Cash flows from financing activities
Debt repayment
-
-
-
0
-35
Common stock issued
0
0
4,941
0
2,116
Common stock repurchased
-471.121
-471.121
0
-
-
Net cash used provided by (used for) financing activities
-471.121
-471.121
4,941
3,794
2,135
Net change in cash
-7,843
-7,843
1,530
8,709
1,017
Cash at beginning of period
11,367
11,367
9,837
1,128
111.752
Cash at end of period
3,524
3,524
11,367
9,837
1,128
Free cash flow
Operating cash flow
-3,224
-3,224
-3,498
-2,278
-1,157
Free cash flow
-3,224
-3,224
-3,498
-2,278
-1,157